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Castration plus oestrogen treatment induces but castration alone
suppresses epithelial cell apoptosis in an androgen-sensitive rat prostatic
adenocarcinoma
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S_inary The positive effect of castration in prostatic cancer patients is considered to be related to the
induction of apoptosis in androgen-d;pendent tumour cells. However, castration apparently does not induce
apoptosis in the highly differentiated, androgen-sensitive Dunning R3327PAP rat prostatic adenocarcinoma.
To elucidate potential mechanisms of apoptotic induction in this tumour model, rats with subcutaneously
implanted tumours were treated with vehick (T), castration + vehicle (C) or castration + 50iLg of oestradiol
benzoate per day s.c. (C+E2). The effects on tumours were examined by morphometry, in situ end labelling
(ISEL) of apoptotic cells and immunohistochemically with monoclonal antibodies to proliferating cell nuckar
antigen (PCNA) at different time points up to 168 h after castration. Castration inhibited tumour growth and
decreased the epithelial cell apoptotic rate (from 12 h) and epithelial cell proliferation rate (from 72 h)
compared with that in the I group. Tumour volume, volume densities of epithelium and stroma and stroma
cell proliferation rate remained constant in the C group during the study period. C+E2 treatment resulted in
increases in cell proliferation in the stroma (from 12 h) and in the volume density of stroma (from 24h)
compared with that in the C and I groups. The number of apoptotic epithelial cells was increased (from 24 h),
and this was followed by decreases in the volume density of epithelium (from 24 h), the epithelial cell
proliferation rate (from 72 h) and the total tumour volume (from 72 h). We conclude that in the Dunning
R3327PAP tumour model C+E2 treatment is more effective than castration alone. C+E2 treatment, in
contrast to C, is able to induce tumour cell death and to decrease total tumour volume. The mechanism
behind this effect is unknown, but it could be related to stimulatory effects of E2 in the tumour stroma.
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Apoptosis is a physiological type of cell death that, together
with cell proliferation, regulates cell numbers in normal and
neoplastic tissues (Kerr et al., 1972). Aberrant down-
regulation of apoptosis may be important in the development
of tumours (Umansky, 1982; McDonnell and Korsmeyer,
1991), and the mechanisms regulating apoptotic rate are
potential targets for cancer therapy. This treatment concept
is particularly interesting in the case of prostatic cancer as
these tumours proliferate very slowly and are thus resistant
to common chemotherapeutic agents (Raghavan, 1988). Cast-
ration, a standard treatment for metastatic prostatic cancer,
results within a week in the apoptotic death of approximately
80% of the normal epithelial cells of the prostate (Kyprianou
and Isaacs, 1988; English et al., 1989), but less is known
about how prostatic tumour cells respond.
Androgen withdrawal has been shown to induce apoptosis
in androgen-dependent PC-82 tumour cells (Kyprianou et al.,
1990) grown in nude mice (vanWerden et al., 1993). In
contrast, in two of the most widely used model systems for
the study of andorgen-sensitive highly differentiated prostatic
carcinoma, the human LnCap and the rat Dunning R3327
PAP prostatic carcinomas, castration reduces tumour growth
and cause epithelial cell shrinkage but does apparently not
induce apoptosis, at least not during the first weeks after
treatment (Westin et al., 1993; Brandstr6m et al., 1994;
Gleave et al., 1992). It is therefore of interest to examine why
apoptosis does not occur after castration and if it can be
induced by additional treatments in an androgen-sensitive
prostatic tumour. Interestingly, treatment with oestrogen has
been shown to induce single-cell pyknosis in human prostatic
tumours (Schenken et al., 1943), to reduce the number of
epithelial cells in the Dunning R3327PAP tumour (Land-
str6m et al., 1990) and to increase the number of mor-
phologically apoptotic cells in Dunning R3327PAP tumours
relapsing after castration treatment (Landstr6m et al., 1994).
The present study was therefore designed to compare short-
term effects of oestrogen treatment in combination with cast-
ration with castration treatment alone in the Dunning R3327
PAP prostatic tumour model.
MNatera and methods
Aninals, treatments and tissue preparation
Ten-week-old male Copenhagen/Fisher rats supplied from
M0llegaard, Copenhagen, Denmark were inoculated
bilaterally with small pieces of the highly differentiated,
androgen-sensitive Dunning R3327PAP prostatic adenocar-
cinoma (originally obtained from Dr Norman N Altman, the
Papanicolau Cancer Research Institute, Miami, FL, USA).
The rats were kept in a controlled environment (12 h dark/
12 h light) and fed rat pellets and tap water ad libitwn. When
the rats weighed about 400 g and the tumours had reached
similar sizes (about 1500 mm3), about 3 months after inocula-
tion, they were randomly divided into three groups. The rats
in two of these groups were castrated via the scrotal route.
The others served as controls. Of the 40 castrated rats, 20
were treated with daily subcutaneous (s.c.) injections of 50 jig
of oestradiol benzoate (Sigma, USA) in sesame oil (C + E2),
and 20 with only sesame oil s.c.(C). Of the remaining 25
non-castrated rats, five were killed before therapy and the
remainder were injected daily with sesame oil (I). After 12,
24, 72 or 168 h, five rats from each of the three groups were
sacrificed by decapitation. The tumours were then removed
and divided into small pieces. Randomly, from each tumour:
(1) Two pieces were put in Bouin's solution, dehydrated and
embedded in methacrylate plastic, cut into 2-nm-thick
sections and stained with eosin for light microscopic
examination of volume densities of different tumour com-
partments (see below).
(2) Five small tissue pieces were fixed by immersion in 4%
formaldehyde, 3% glutaraldehyde and 0.5% picric acid
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dehydrated, embedded in Epon and cut into 1-zm-thick
sections, which were stained with toluidine blue for light
microscopical demonstration of mitotic and apoptotic
cells (see below).
(3) One piece was put in methanol and one in buffered
formalin for 24 h. These tissue pieces were then dehyd-
rated, embedded in paraffin and cut into 4 -n-thick
sections for immunohistochemcal and in situ end-
labelling (ISEL) examinations (see below).
Tumour vohlne, morphology andmorphometry
Before castration and before killing the animals, tumour
volumes (L x W x H x 0.5236) were measured with a micro-
calliper (Landstr6m et al., 1990). This estimation of tumour
volume is highly correlated with tumour weight (Landstr6m
et al., 1990). The volume densities of epithelium, glandular
hunina and stroma were determined using a point counting
method; a square lattice was mounted in the eyepiece of a
light microscope and hits falling over the different tissue
compartments were counted as earlier described (Landstrom
et al., 1990).
Mitotic and apoptotic indices (percentage of apoptotic and
mitotic cells) were determined by counting 3000 epithelal
and 1500 stromal cells per tumour at 1000 x magniication.
Apoptotic cells were defined as single rounded cells or
fragments with densely aggregated chromatin and condensed
cytoplasm, often lying in 'halos' of extracenlular space (Kerr
et al., 1972). If more than one apoptotic body was seen per
'halo', these were considered to orginate from the same cell
and counted as one.
Detection ofproliferating cells
For immunohistochemical detection of proliferating (cycling)
cells, a monoclonal anti-proliferating cell nuclear antigen
(PCNA) antibody was used (Landberg and Roos, 1991).
Sections of the paraffin-embedded, methanol-fixed tumour
pieces were deparaffinised, treated again with methanol to
suppress endogenous peroxidase activity, washed with
phosphate-buffered saline (PBS) and incubated overnight
with a primary monoclonal anti-PCNA antibody (Dako
M879, Dakopatts, Denmark). The sections were then
incubated with a secondary biotinylated antibody for 30min,
followed by ABC reagents for 45 min and with peroxidase
substrate for development for 15 min. Between incubations,
the sections were washed for 10 min in PBS. After
immunodetection, the sections were lightly counterstained
with Meyer's haematoxylin solution. PCNA indices (percen-
tage of PCNA labelled cells) were determined by counting
900 epithelial and 300 stromal cells per tumour at
1000 x magnification.
In situ detection ofapoptotic cells
Along with the time-and labour-consuming electron micros-
copic detection of apoptotic cells, the novel and more con-
venient (ISEL or in situ nick translation methods are con-
sidered to be the most accurate in detecting apoptotic cells
(Ansari et al., 1993; Wijsman et al., 1993). Basically, the
protocol by Wijsman et al. was followed.
After dewaxing and rehydration of formalin-fixed tissue
according to standard procedures, the sections were heated in
2 x SSC (0.3 M sodium chloride and 30mM sodium citrate),
pH 7, at 80-C for 20min and subsequently washed
thoroughly in distilled water. To enable enzymatic incorpora-
tion of nucleotides, the sections were digested in 0.5% pepsin
in hydrochloric acid (pH 2) for 15 min with gentle shaing in
a 37C water bath. The digestion was stopped by washing
several times in tap water and then in buffer A
[50mM Tris-HCI, 5 mM magnesium chloride, 10 mM P-
mercaptoethanol and 0.005% bovine serm albumin (BSA;
Sigma), pH 7.5] for 5 min. After drying, the sections were
incubated for 1 h at I5C with buffer A containing 0.01 mM
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dATP, dGTP, dCTP 0.01 mm biotin dUTP (Boehringer-
Mannheim) and 4 Uml-' DNA polymerase I (Sigma). After
blockng endogenous peroxidase for 5 min in 0.1% hydrogen
peroxide in PBS, the sections were washed twice for 5 min in
0.1% hydrogen peroxide in PBS. The sections were then
incubated with avidin (Boehringer-Mannhim) dissolved in
PBS containing 1% BSA and 0.5% Tween 20 for 30min at
room temperature before developing with diaminobenzidine
(Sigma). For negative controls, DNApolymerase was exc-
luded from the nucleotide-polymerase mix. For positive con-
trols, normal rat prostate was used 3 days after castration
since about 4% of the epitheial cells are known to be
apoptotic at this time (English et al., 1989). ISEL indexes
(percentage of ISEL-positive cells) were determined by coun-
ting approximately 3000 cells per tumour at 1000 x
magnifcation.
Statistics
For comparisons between groups the Mann-Whitney U-test
was employed. Correlation was expressed using linear regres-
sion analysis. A P-value of less than 0.05 was considered
statistically significant.
Resdts
Tumour volune
In the vehicle-treated intact animals the tumour volume in-
creased during the study period (Figure 1). Castration
inhibited tumour growth and the tumour vohlne remained
constant. In contrast, castration plus oestrogen treatment
reduced tumour volume from 72 h after treatment (Figure 1).
Twnour morphology andcomposition
The vohlme densities of epithelium, stroma and glandular
lumina (not shown) reained constant during the study
period in the intact and the castrated group (Figure 2a and
b). In contrast, in the castrated + oestrogen-treated group the
volume densities of tumour epithelium decreased and stroma
increased as early as after 24 h of treatment (Figure 2a and
b). The volume density of lumina was, however, unaffected
(not shown). Necrotic tumour areas were rarely observed in
intact, castrated, or castrated + oestrogen-treated tumours.
Mitotic and PCNA labelling index
The caculated PCNA labelling indices and mitotic indexes in
the individual tumours were highly correlated (r= 0.98,
P<0.00001, n = 65). Therefore, only the data on
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Fwe 1 Relative changs in average tmour volume ofindivd-
ual Dunning tumours treated with vehicle (1), castration +vehicle
(C) and with casration + oestrogcn (C + E2) after 0, 12, 24, 72
and 168 h of treatment. Each point in the diagram esents
7-10 tumours. a = significantly different from I group,
b=significantly different from Cgroup, P<0.05 accrding to
Mann-Whitney U-test Error bars represent s.em. For details,
see the Materials and methods and Results sectons.
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PCNA labelling are presented. The number of mitotic or
PCNA-labelled stroma cells remained constant during the
study period in the intact or in the castrated group (Figures
3a and 6). In the castrated + oestrogen-treated group these
values increased considerably as early as 12 h after treatment,
but they returned to basal values at 168 h (Figures 3a and 6).
The number of mitotic or PCNA-labelled tumour epithelial
cells did not change in intact animals, but in castrated
animals it decreased at 72 and 168 h (Figure 3b). In the
castrated + oestrogen-treated animals there was an even more
marked reduction in epithelial cell proliferation at 72 and
168 h (Figure 3b). In all groups the percentage of PCNA-
labelled tumour epithelial cells correlated with the relative
change in tumour volume during the study period (r = 0.51,
P<0.0001). It should be noted that PCNA index may inc-
rease under some circumstances in non-proliferating cells
(Harrison et al., 1993). However, the correlation between
PCNA and mitotic indexes suggest that the PCNA-labelling
index is related to cell proliferation in the circumstances
studied here.
Apoptosis
Apoptotic,ISEL-positive cells were extremely rare outside the
epithelial compartment. The epithelial cell apoptotic and
ISEL indexes in individual tumours were highly correlated
(r=0.99, P<0.0001. n=30). For this reason we only per-
formed ISEL in the 12 and 24 h groups. The ISEL and
apoptotic indexes were unchanged during the study period in
the intact group (Figures 4 and 5). Castration resulted in a
significant reduction in the number of apoptotic cells (com-
pared with the I and C + E2 groups) starting as early as 12 h
after treatment. The apoptotic indexes (ISEL indexes at 24 h)
were significantly higher in the C + E2 than in the C and I
groups at 24, 72 and 168 h after treatment (Figures 4 and 6).
There was a large increase in the number of ISEL-positive
cells in the ventral prostate 3 days after castration (data not
shown), confirming the effectiveness of the ISEL method in
detecting apoptotic cells. The rarely observed necrotic areas
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Figue 3 Stromal (a) and epithehal (b) PCNA incorporation (a)
in individual Dunning tumours treated with vehicle (I), castra-
tion + vehicle (C) and with castration + oestrogen (C + E2) after
0, 12, 24, 72 and 168 h of treatment. Each point in the diagram
represents 4-6 tumours. a = significantly different from I group,
b = significantly different from C group, P<0.05 according to
Mann-Whitney U-test. Error bars represent s.e.m. For details,
see the Materials and methods and Results sections.
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Figure 4 Tumour epithehal cell apoptotic indexes of individual
C Dunning tumours treated with vehicle (I), castration + vehicle (C)
and with castration + oestrogen (C + E2) after 0. 12, 24, 72 and
168 h of treatment. Each point in the diagram represents 4-8
tumours. a = significantly different from I group, b = significantly
different from C-group, P<0.05 according to Mann-Whitney
I , IX U-test. Error bars represent s.e.m. For details, see the Materials
72 168 and methods and Results sections.
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Fue 2 Stromal (a) and epithelial (b) volume density of individ-
ual Dunning tumours treated with vehicle (I), castration + vehicle
(C) and with castration + oestrogen (C + E2) after 0, 12. 24, 72
and 168 h of treatment. Each point in the diagram represents 4-6
tumours. a = significantly different from I group, b = significantly
different from Cgroup. P<0.05 according to Mann-Whitney
U-test. Error bars represent s.e.m. For details, see the Materials
and methods and Results sections.
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Figure 5 In situ end labelling (ISEL) indexes of individual Dun-
ning tumours treated with vehicle (I), castration + vehicle (C) and
with castration + oestrogen (C + E2) after 12 and 24 h of treat-
ment. Each bar in the diagram represents 5-7 tumours.
a = significantly different from I group, b = significantly different
from C group, P<0.05 according to Mann-Whitney U-test.
Error bars represent s.e.m. For details, see the Materials and
methods and Results sections.
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-were also stained by ISEL but were easily distinguished from
apoptotic cells.
One important observation in this study is that castration
reduces the apoptotic index and therefore probably the
number of apoptotic epithelial cells in the androgen-sensitive
Dunning R3327PAP tumour. We have previously suggested
that the principal reason for the inhibited tumour growth
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observed in this model after castration could be a decreased
epithelial cell proliferation rate and epithelial cell atrophy,
and not an increased apoptotic rate (Westin et al., 1993;
Brandstr6m et al., 1994). The present findings support this
conclusion and offer an explanation for our previous finding
that. in spite of a reduced cell proliferation rate, epithelial
cell numbers are unaffected compared with that in untreated
tumours up to 6 weeks after castration in this tumour model
(Landstr6m et al.. 1990). Moreover, as aberrant cell survival
can contribute to tumour progression in different ways (Car-
son and Ribeiro. 1993). it is not surprising that the inhibitory
la b
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Figwe 6 Section from Dunning tumours treated for 24 h with castration + vehicle (a, c, and e) and castration + oestrogen (b, d,
and f). (a and b) Epon sections, 700 x magnification. Arrowheads on apoptotic cells. Considerably more apoptotic cells are found
in C + E2-treated tumours (b), which also show proliferating stromal cells (arrow on mitotic large stromal cell). Apoptotic cells are
found in the epithelium. (c and d) Sections from in situ end labelling of apoptotic cells, 700 x magnification. Arrowheads on stained
apoptotic cells. Considerably more stained cells are found in C + E2-treated tumours (d). Staining cells are of epithelial origin. (e
and f) Sections from immunohistochemical labelling of cycling cells with monoclonal antibodies to PCNA, 175 x magnification.
Arrows on stained stromal cells (large stromal cells and fibroblasts). Considerably more stromal cells are stained in C + E2-treated
tumours (f).
aTuw apsis- s by roW n
P Westn etat
144
effect of castration on tumour growth rate is transient in this
tumour model (Landstr6m et al., 1994). It has previously
been shown that androgens stimulate cell proliferation and
inhibit cell death in the rat ventral prostate (Isaacs, 1984).
The present observation suggests that cell proliferation, but
not cell death, may be controlled in the same way in the
Dunning R3327PAP tumour model. The reason why regula-
tion of cell death and proliferation are apparently dissociated
in this tumour remains to be studied.
According to current opinion, prostatic tumours that res-
pond to androgen ablation therapy are composed of
androgen-dependent and androgen-independent cells. The
androgen-dependent cells presumably die after androgen
ablation therapy and the independent ones survive and even-
tually repopulate the tumour (Isaacs and Coffey, 1981). How-
ever, this concept may not be valid for the Dunning
R3327PAP tumour. There are no indications that androgen-
dependent cells are present in this tumour as there are no
signs of castration-induced cell death. The tumour cells are
not androgen independent since they do respond to treatment
with a decreased proliferation rate and atrophy (Landstr6m
et al., 1990; Westin et al., 1993). It therefore appears that this
tumour is composed mainly of an androgen-sensitive cell
population. How relevant then is this tumour model for
human prostatic cancer? This question cannot be answered at
present. Preliminary data do, however, indicate that castra-
tion therapy causes tumourcell atrophy and decreased cell
proliferation rate, but not apoptotic cell death, in several
prostatic cancer patients and that a subgroup of these
tumours may respond with a decreased apoptotic rate (Wes-
tin et al., 1995).
Another interesting finding in the present study is that
combined oestrogen and castration treatments result in a
3-fold increase in cell death rate 24 h after the start of
treatment, which is then maintained at a significantly higher
level than in untreated tumours. Theoretically, an increased
apoptotic index could reflect a decreased rate at which apop-
totic bodies are phagocytosed. However, as tumour volume
and epithelial volume density were decreased, a more likely
explanation for the observed increase in the number of apop-
totic epithelial cells in these tumours is that more cells are
actually dying by apoptosis. The magnitude of the apoptotic
response to oestrogen treatment, though relatively small, is
significant since it, together with the decrease in cell pro-
liferation and possibly in cell size (Landstr6m et al., 1990),
results in a 30% decrease in tumour volume during the study
period.
The observation that oestrogen + castration treatment may
induce apoptosis in an androgen-sensitive prostatic cancer
model is interesting as it suggests that there could be addi-
tional perhaps more effective ways than castration to induce
cell death in prostatic tumours.
Oestrogen may act in several ways. It may have direct
effects on the tumour epithelial cells, as suggested by the
observation of apoptosis in a prostatic tumour cell line after
treatment with diethylstilboestrol in vitro (Fine et al., 1994).
The mechanism behind this is unknown, but oestrogen treat-
ment is able to release intracellular calcium levels via an
unconventional cell-surface oestrogen receptor in granulosa
cells (Morley et al., 1992), and increase in intracellular Ca2+
may activate key enzymes such as endonuclease and tis-
sue transglutaminase involved in apoptosis (Fesus et al.,
1991). However, observations in this study suggest that the
effect of oestrogen could be secondary to effects in the
tumour stroma; the increase in epithelial cell apoptosis was
preceded by a proliferative response in the stroma. Moreover,
oestrogen receptors in the Dunning R3327PAP tumour are
located mainly in the stroma (Markland et al., 1978; Beck-
man et al., 1985), and it has also been shown that oestrogen
exerts stimulatory effects on the stroma of the normal pros-
tate (KErieg et al., 1983) as well as that in Dunning
R3327PAP tumours (Landstr6m et al., 1990). Interestingly, it
has also been noted that signs ofincreased activity in stromal
cells occur simultaneously with epithelial cell apoptosis after
castration in the normal prostate (Bacher et al., 1993; Zhao
et al., 1993) and in the PC-82 human prostatic tumour model
(vanWerden et al., 1993). Stromal cells in all tissues may, by
providing 'survival signals', regulate cell death rate in the
adjacent parenchymal cells (Raff, 1992). By secreting
stimulatory and inhibitory factors and by providing extracel-
lular matrix stroma cells may regulate epithelial cell survival,
differentiation and growth in the normal, hyperplastic and
malignant prostate (Oosterwijk-K6nig et al., 1985; Cunha et
al., 1986; K6nig et al., 1987; Chung, 1993; Meredith et al.,
1993; Frisch and Francis, 1994). We therefore suggest that
the reason why combined oestrogen and castration treatment,
in contrast to castration alone, induces epithelial cell apop-
tosis in the Dunning R3327PAP tumour is that it has a
stimulatory effect on its stroma. This hypothesis is currently
under investigation.
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